Clinical significance of P53 and Bcl-2 in acute myeloid leukemia patients of Eastern India.

about

The role of p53 in myelodysplastic syndromes and acute myeloid leukemia: molecular aspects and clinical implications.Bax, Bcl-2, and Bax/Bcl-2 as prognostic markers in acute myeloid leukemia: are we ready for Bcl-2-directed therapy?

P2860

Q52777531-755B92E7-2955-4D34-B6F8-E03234D92690 Q53702234-E39792E9-408F-4DDC-BD32-B19E88F24589

P2860

Clinical significance of P53 and Bcl-2 in acute myeloid leukemia patients of Eastern India.

Item

http://www.wikidata.org/entity/Q35720084

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Clinical significance of P53 a ...... mia patients of Eastern India.

@ast

Clinical significance of P53 a ...... mia patients of Eastern India.

@en

type

Item

label

Clinical significance of P53 a ...... mia patients of Eastern India.

@ast

Clinical significance of P53 a ...... mia patients of Eastern India.

@en

prefLabel

Clinical significance of P53 a ...... mia patients of Eastern India.

@ast

Clinical significance of P53 a ...... mia patients of Eastern India.

@en

P1476

Clinical significance of P53 a ...... mia patients of Eastern India.

@en

P2093

Geetaram Sahu

http://www.w3.org/2001/XMLSchema#string

Rabindra Kumar Jena

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of Bax channel-forming activity by Bcl-2

Mutations in the p53 gene occur in diverse human tumour types

p53 mutations in human cancers

Diminished cell proliferation associated with the death-protective activity of Bcl-2

p53 function and dysfunction.

Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia

Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.

The p53 tumour suppressor gene.

Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer.

Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer.

P304

e28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4081/HR.2011.E28

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224972843

http://www.w3.org/2001/XMLSchema#string

P698

22593819

http://www.w3.org/2001/XMLSchema#string

P921

India

P932

3269804

http://www.w3.org/2001/XMLSchema#string

Clinical significance of P53 and Bcl-2 in acute myeloid leukemia patients of Eastern India.

about

P2860

P2860

Clinical significance of P53 and Bcl-2 in acute myeloid leukemia patients of Eastern India.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932